Table of Contents
Chapter 1. Global Epigenomics Market Executive Summary
1.1. Global Epigenomics Market Size & Forecast (2024-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Technology
1.3.3. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Epigenomics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Epigenomics Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Research in Epigenetics
3.1.2. Rising Incidence of Chronic Diseases
3.1.3. Advancements in Epigenetic Technologies
3.2. Market Challenges
3.2.1. High Cost of Epigenetic Research
3.2.2. Complexity of Epigenetic Mechanisms
3.3. Market Opportunities
3.3.1. Personalized Medicine Advancements
3.3.2. Interdisciplinary Collaborations
3.3.3. Public and Private Funding Increases
Chapter 4. Global Epigenomics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Epigenomics Market Size & Forecasts by Product Type 2024-2032
5.1. Segment Dashboard
5.2. Global Epigenomics Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Reagents
5.2.2. Kits
5.2.3. Enzymes
5.2.4. Others
Chapter 6. Global Epigenomics Market Size & Forecasts by Technology 2024-2032
6.1. Segment Dashboard
6.2. Global Epigenomics Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. DNA Methylation
6.2.2. Histone Methylation
6.2.3. Histone Acetylation
6.2.4. MicroRNA Modification
6.2.5. Large Non-coding RNA
6.2.6. Chromatin Structures
6.2.7. Others
Chapter 7. Global Epigenomics Market Size & Forecasts by Application 2024-2032
7.1. Segment Dashboard
7.2. Global Epigenomics Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Pharmaceutical
7.2.2. Diagnostics
Chapter 8. Global Epigenomics Market Size & Forecasts by Region 2024-2032
8.1. North America Epigenomics Market
8.1.1. U.S. Epigenomics Market
8.1.1.1. Product Type breakdown size & forecasts, 2024-2032
8.1.1.2. Technology breakdown size & forecasts, 2024-2032
8.1.1.3. Application breakdown size & forecasts, 2024-2032
8.1.2. Canada Epigenomics Market
8.1.2.1. Product Type breakdown size & forecasts, 2024-2032
8.1.2.2. Technology breakdown size & forecasts, 2024-2032
8.1.2.3. Application breakdown size & forecasts, 2024-2032
8.2. Europe Epigenomics Market
8.2.1. U.K. Epigenomics Market
8.2.1.1. Product Type breakdown size & forecasts, 2024-2032
8.2.1.2. Technology breakdown size & forecasts, 2024-2032
8.2.1.3. Application breakdown size & forecasts, 2024-2032
8.2.2. Germany Epigenomics Market
8.2.2.1. Product Type breakdown size & forecasts, 2024-2032
8.2.2.2. Technology breakdown size & forecasts, 2024-2032
8.2.2.3. Application breakdown size & forecasts, 2024-2032
8.2.3. France Epigenomics Market
8.2.3.1. Product Type breakdown size & forecasts, 2024-2032
8.2.3.2. Technology breakdown size & forecasts, 2024-2032
8.2.3.3. Application breakdown size & forecasts, 2024-2032
8.2.4. Spain Epigenomics Market
8.2.4.1. Product Type breakdown size & forecasts, 2024-2032
8.2.4.2. Technology breakdown size & forecasts, 2024-2032
8.2.4.3. Application breakdown size & forecasts, 2024-2032
8.2.5. Italy Epigenomics Market
8.2.5.1. Product Type breakdown size & forecasts, 2024-2032
8.2.5.2. Technology breakdown size & forecasts, 2024-2032
8.2.5.3. Application breakdown size & forecasts, 2024-2032
8.2.6. Rest of Europe Epigenomics Market
8.2.6.1. Product Type breakdown size & forecasts, 2024-2032
8.2.6.2. Technology breakdown size & forecasts, 2024-2032
8.2.6.3. Application breakdown size & forecasts, 2024-2032
8.3. Asia-Pacific Epigenomics Market
8.3.1. China Epigenomics Market
8.3.1.1. Product Type breakdown size & forecasts, 2024-2032
8.3.1.2. Technology breakdown size & forecasts, 2024-2032
8.3.1.3. Application breakdown size & forecasts, 2024-2032
8.3.2. India Epigenomics Market
8.3.2.1. Product Type breakdown size & forecasts, 2024-2032
8.3.2.2. Technology breakdown size & forecasts, 2024-2032
8.3.2.3. Application breakdown size & forecasts, 2024-2032
8.3.3. Japan Epigenomics Market
8.3.3.1. Product Type breakdown size & forecasts, 2024-2032
8.3.3.2. Technology breakdown size & forecasts, 2024-2032
8.3.3.3. Application breakdown size & forecasts, 2024-2032
8.3.4. Australia Epigenomics Market
8.3.4.1. Product Type breakdown size & forecasts, 2024-2032
8.3.4.2. Technology breakdown size & forecasts, 2024-2032
8.3.4.3. Application breakdown size & forecasts, 2024-2032
8.3.5. South Korea Epigenomics Market
8.3.5.1. Product Type breakdown size & forecasts, 2024-2032
8.3.5.2. Technology breakdown size & forecasts, 2024-2032
8.3.5.3. Application breakdown size & forecasts, 2024-2032
8.3.6. Rest of Asia Pacific Epigenomics Market
8.3.6.1. Product Type breakdown size & forecasts, 2024-2032
8.3.6.2. Technology breakdown size & forecasts, 2024-2032
8.3.6.3. Application breakdown size & forecasts, 2024-2032
8.4. Latin America Epigenomics Market
8.4.1. Brazil Epigenomics Market
8.4.1.1. Product Type breakdown size & forecasts, 2024-2032
8.4.1.2. Technology breakdown size & forecasts, 2024-2032
8.4.1.3. Application breakdown size & forecasts, 2024-2032
8.4.2. Mexico Epigenomics Market
8.4.2.1. Product Type breakdown size & forecasts, 2024-2032
8.4.2.2. Technology breakdown size & forecasts, 2024-2032
8.4.2.3. Application breakdown size & forecasts, 2024-2032
8.4.3. Rest of Latin America Epigenomics Market
8.4.3.1. Product Type breakdown size & forecasts, 2024-2032
8.4.3.2. Technology breakdown size & forecasts, 2024-2032
8.4.3.3. Application breakdown size & forecasts, 2024-2032
8.5. Middle East & Africa Epigenomics Market
8.5.1. Saudi Arabia Epigenomics Market
8.5.1.1. Product Type breakdown size & forecasts, 2024-2032
8.5.1.2. Technology breakdown size & forecasts, 2024-2032
8.5.1.3. Application breakdown size & forecasts, 2024-2032
8.5.2. South Africa Epigenomics Market
8.5.2.1. Product Type breakdown size & forecasts, 2024-2032
8.5.2.2. Technology breakdown size & forecasts, 2024-2032
8.5.2.3. Application breakdown size & forecasts, 2024-2032
8.5.3. Rest of Middle East & Africa Epigenomics Market
8.5.3.1. Product Type breakdown size & forecasts, 2024-2032
8.5.3.2. Technology breakdown size & forecasts, 2024-2032
8.5.3.3. Application breakdown size & forecasts, 2024-2032
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Novartis AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Abbott Laboratories
9.3.3. Abcam plc
9.3.4. Zymo Research Corporation
9.3.5. Agilent Technologies Inc.
9.3.6. Epizyme Inc.
9.3.7. Boehringer Ingelheim International GmbH
9.3.8. Bayer AG
9.3.9. Thermo Fisher Scientific Inc.
9.3.10. Illumina Inc.
9.3.11. Merck KGaA
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes